- Home
- XNCR vs SIBN Comparison
XNCR vs SIBN Comparison
Compare XNCR & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- SIBN
- Stock Information
- Founded
- XNCR 1997
- SIBN 2008
- Country
- XNCR United States
- SIBN United States
- Employees
- XNCR N/A
- SIBN N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- SIBN Medical/Dental Instruments
- Sector
- XNCR Health Care
- SIBN Health Care
- Exchange
- XNCR Nasdaq
- SIBN Nasdaq
- Market Cap
- XNCR 579.3M
- SIBN 571.0M
- IPO Year
- XNCR 2013
- SIBN 2018
- Fundamental
- Price
- XNCR $9.65
- SIBN $18.90
- Analyst Decision
- XNCR Buy
- SIBN Strong Buy
- Analyst Count
- XNCR 8
- SIBN 5
- Target Price
- XNCR $29.29
- SIBN $24.40
- AVG Volume (30 Days)
- XNCR 968.8K
- SIBN 505.0K
- Earning Date
- XNCR 08-04-2025
- SIBN 08-04-2025
- Dividend Yield
- XNCR N/A
- SIBN N/A
- EPS Growth
- XNCR N/A
- SIBN N/A
- EPS
- XNCR N/A
- SIBN N/A
- Revenue
- XNCR $127,228,000.00
- SIBN $176,601,000.00
- Revenue This Year
- XNCR N/A
- SIBN $19.48
- Revenue Next Year
- XNCR $29.35
- SIBN $16.75
- P/E Ratio
- XNCR N/A
- SIBN N/A
- Revenue Growth
- XNCR N/A
- SIBN 22.60
- 52 Week Low
- XNCR $7.16
- SIBN $11.70
- 52 Week High
- XNCR $27.24
- SIBN $20.05
- Technical
- Relative Strength Index (RSI)
- XNCR 59.62
- SIBN 61.18
- Support Level
- XNCR $8.76
- SIBN $18.37
- Resistance Level
- XNCR $9.60
- SIBN $19.33
- Average True Range (ATR)
- XNCR 0.52
- SIBN 0.56
- MACD
- XNCR 0.29
- SIBN -0.16
- Stochastic Oscillator
- XNCR 90.87
- SIBN 50.57
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.